This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of Southern California. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Peter Kuhn
Introduction
Peter Kuhn is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of biomedical engineering, particularly in the area of liquid biopsy and survival prediction models. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics and treatment.
Latest Patents
Kuhn's latest patents include "Systems, methods and assays for outlier clustering unsupervised learning automated report (OCULAR)." This innovative system identifies biological structures present in liquid biopsy samples by analyzing their fluorescence characteristics and morphology. The identified structures can be crucial for diagnosing and treating diseases in humans. Another significant patent is the "System and method for predicting survival time." This method utilizes clinical data and liquid biopsy data to predict an individual's survival time using a deep learning model. The output of this method can provide valuable insights into patient care.
Career Highlights
Peter Kuhn is affiliated with the University of Southern California, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on healthcare and patient outcomes.
Collaborations
Kuhn collaborates with various professionals in his field, including his coworker Yan Liu. Their combined expertise contributes to the development of cutting-edge technologies in medical diagnostics.
Conclusion
Peter Kuhn's contributions to the field of biomedical engineering through his patents and research are noteworthy. His innovative approaches to liquid biopsy and survival prediction are set to enhance medical diagnostics and treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
